KFSHRC Launches the First Facility for Gene and Cell Therapy Manufacturing in Saudi Arabia
KFSHRC Launches the First Facility for Gene and Cell Therapy Manufacturing in Saudi Arabia At Global Health Exhibition 2025 held...
Day: October 27, 2025
Tria Federal Joins ServiceNow Partner Program to Power Digital Transformation in Government
Tria Federal joins ServiceNow Partner Program to power digital transformation in government Tria Federal (Tria) has joined the ServiceNow Partner...
Tria Federal Joins ServiceNow Partner Program to Power Digital Transformation in Government
Tria Federal joins ServiceNow Partner Program to power digital transformation in government Tria Federal (Tria) has joined the ServiceNow Partner...
Tria Federal Joins ServiceNow Partner Program to Power Digital Transformation in Government
Tria Federal joins ServiceNow Partner Program to power digital transformation in government Tria Federal (Tria) has joined the ServiceNow Partner...
Creative Medical Technology Holdings Issues Letter to Shareholders
Ongoing Phase II Clinical Trials, Recently Issued Patents, and AI Integration Initiatives Set the Stage for Continuing Progress in 2026PHOENIX, Oct....
Creative Medical Technology Holdings Issues Letter to Shareholders
Ongoing Phase II Clinical Trials, Recently Issued Patents, and AI Integration Initiatives Set the Stage for Continuing Progress in 2026PHOENIX, Oct....
Creative Medical Technology Holdings Issues Letter to Shareholders
Ongoing Phase II Clinical Trials, Recently Issued Patents, and AI Integration Initiatives Set the Stage for Continuing Progress in 2026PHOENIX, Oct....
Pacira BioSciences Notified of Abbreviated New Drug Application Filing from Qilu Pharmaceutical (Hainan) Co., Ltd. for EXPAREL®
BRISBANE, Calif., Oct. 27, 2025 (GLOBE NEWSWIRE) -- Pacira BioSciences, Inc. (Nasdaq: PCRX), the industry leader in its commitment to...
Pacira BioSciences Notified of Abbreviated New Drug Application Filing from Qilu Pharmaceutical (Hainan) Co., Ltd. for EXPAREL®
BRISBANE, Calif., Oct. 27, 2025 (GLOBE NEWSWIRE) -- Pacira BioSciences, Inc. (Nasdaq: PCRX), the industry leader in its commitment to...
Pacira BioSciences Notified of Abbreviated New Drug Application Filing from Qilu Pharmaceutical (Hainan) Co., Ltd. for EXPAREL®
BRISBANE, Calif., Oct. 27, 2025 (GLOBE NEWSWIRE) -- Pacira BioSciences, Inc. (Nasdaq: PCRX), the industry leader in its commitment to...
Simbryo Technologies Introduces Personalized Assay to Help IVF Patients Avoid Repeated Failed Transfers
New diagnostic addresses critical gap in IVF care—measuring whether the uterus is ready to support an embryo Study shows test...
Simbryo Technologies Introduces Personalized Assay to Help IVF Patients Avoid Repeated Failed Transfers
New diagnostic addresses critical gap in IVF care—measuring whether the uterus is ready to support an embryo Study shows test...
Simbryo Technologies Introduces Personalized Assay to Help IVF Patients Avoid Repeated Failed Transfers
New diagnostic addresses critical gap in IVF care—measuring whether the uterus is ready to support an embryo Study shows test...
Inspire Medical Systems, Inc. to Present at the 2025 UBS Global Healthcare Conference
MINNEAPOLIS, Oct. 27, 2025 (GLOBE NEWSWIRE) -- Inspire Medical Systems, Inc. (NYSE: INSP) (Inspire), a medical technology company focused on...
Inspire Medical Systems, Inc. to Present at the 2025 UBS Global Healthcare Conference
MINNEAPOLIS, Oct. 27, 2025 (GLOBE NEWSWIRE) -- Inspire Medical Systems, Inc. (NYSE: INSP) (Inspire), a medical technology company focused on...
Inspire Medical Systems, Inc. to Present at the 2025 UBS Global Healthcare Conference
MINNEAPOLIS, Oct. 27, 2025 (GLOBE NEWSWIRE) -- Inspire Medical Systems, Inc. (NYSE: INSP) (Inspire), a medical technology company focused on...
Evaxion appoints Dr Helen Tayton-Martin as new Chief Executive Officer
Dr Tayton-Martin brings broad experience of biotech company building, fund-raising, M&A, business development and operations with a strong track record...
Evaxion appoints Dr Helen Tayton-Martin as new Chief Executive Officer
Dr Tayton-Martin brings broad experience of biotech company building, fund-raising, M&A, business development and operations with a strong track record...
Evaxion appoints Dr Helen Tayton-Martin as new Chief Executive Officer
Dr Tayton-Martin brings broad experience of biotech company building, fund-raising, M&A, business development and operations with a strong track record...
OXB to participate in upcoming investor conferences and events
OXB to participate in upcoming investor conferences and events Oxford, UK – 27 October 2025: OXB (LSE: OXB), a global quality...